Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma

Biomarker Research
Kevin Y Xu, Shenhong Wu

Abstract

The advent of new knowledge surrounding the molecular pathology of renal-cell carcinoma (RCC) has culminated in a number of emerging targeted therapies. In just the last year, several new studies have been able to translate our understanding of tumor biology into significantly improved outcomes in patients with advanced RCC. The objective of this review is to describe new developments in targeted treatments and immunotherapies for patients with both clear-cell and non-clear cell metastatic RCC following the 2014 American Society of Clinical Oncology (ASCO) annual conference. We will discuss new applications of anti-VGF agents and PD-1 inhibitors in order to shed light on emerging avenues of RCC treatment that show considerable promise.

References

Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Feb 17, 2009·Current Oncology Reports·C Lance Cowey, W Kimryn Rathmell
Apr 30, 2009·Cancer·Gary R Hudes
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 8, 2014·Current Treatment Options in Oncology·Anasuya Gunturi, David F McDermott
Jun 11, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B RiniJ R Infante

❮ Previous
Next ❯

Citations

Jan 14, 2016·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Paolo CuratoloSergiusz Jozwiak
May 23, 2015·Human Vaccines & Immunotherapeutics·Katherine A MurphyThomas S Griffith
Jun 25, 2016·International Journal of Molecular Sciences·Moto Kajiwara, Satohiro Masuda
May 10, 2017·Nature Reviews. Nephrology·Hiromi I WetterstenRobert H Weiss
Feb 6, 2017·Journal of Hematology & Oncology·Kevin ZarrabiShenhong Wu
May 16, 2017·The Cochrane Database of Systematic Reviews·Susanne UnverzagtBarbara Seliger
May 22, 2018·Expert Opinion on Biological Therapy·Kevin Zarrabi, Shenhong Wu
Jul 23, 2015·Journal of Hematology & Oncology·Niraj ShenoyAmit Verma
Nov 21, 2018·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Janice P Dutcher
Jul 9, 2020·International Journal of Urology : Official Journal of the Japanese Urological Association·Rebecca C ObengAdeboye O Osunkoya
Sep 6, 2019·Journal of Hematology & Oncology·Kevin ZarrabiShenhong Wu
Jul 30, 2017·Journal of Hematology & Oncology·Delong Liu, Aleksandra Mamorska-Dyga
Aug 21, 2019·Journal of Evidence-based Medicine·Frank PeinemannInes Moldenhauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Cancer Chemotherapy and Pharmacology
David J Reeves, Chin Y Liu
© 2022 Meta ULC. All rights reserved